Rheumatoid arthritis (RA) is a chronic autoimmune disease in which your immune system mistakenly attacks the lining of your joints, causing painful swelling that can eventually damage cartilage and bone. Unlike osteoarthritis, which results from wear and tear, RA is driven by inflammation and typically affects the same joints on both sides of your body. As of 2019, roughly 18 million people worldwide were living with the condition, and about 70% of them are women.
What Happens Inside Your Joints
Every movable joint in your body is lined with a thin membrane called the synovium. In RA, immune cells flood into this membrane, causing it to thicken and swell. The inflamed synovium releases chemicals that gradually eat away at cartilage and bone within the joint. Over time, the joint space narrows, alignment shifts, and movement becomes increasingly difficult.
Two key inflammatory signals drive this process. One, called TNF, amplifies the immune attack on joint tissue. The other, IL-6, fuels both local joint inflammation and body-wide symptoms like fatigue and anemia. Blocking these signals is the basis for several modern RA treatments. Meanwhile, certain cells in the joint lining release chemical attractants that pull even more immune cells into the area, creating a self-reinforcing cycle of damage.
Who Gets RA and Why
RA results from a combination of genetic susceptibility and environmental triggers. The strongest known genetic risk factor is a gene called HLA-DRB1. Certain versions of this gene produce proteins containing a specific amino acid sequence known as the “shared epitope,” and people who carry these variants face a significantly higher chance of developing RA. But genetics alone don’t determine your fate. Many people with these gene variants never develop the disease.
Environmental factors tip the balance. Smoking is the most well-established trigger, particularly for people who carry susceptible gene variants. Hormonal differences likely explain why women are two to three times more likely to develop RA than men. Most people are diagnosed between the ages of 30 and 60, though it can appear at any age.
Early Symptoms to Recognize
The hallmark of RA is symmetrical joint pain, meaning the same joints on both sides of your body are affected at roughly the same time. It most commonly starts in the small joints of the hands and feet, particularly the knuckles and the joints at the base of the toes. Wrists, elbows, shoulders, knees, and ankles can also be involved.
Morning stiffness is one of the most telling early signs. While most people feel a little stiff when they wake up, RA stiffness typically lasts at least 30 minutes and often more than 60. It gradually loosens as you move throughout the day but can return after periods of inactivity. Joints may also feel warm to the touch or look slightly swollen. Fatigue, low-grade fever, and a general sense of feeling unwell are common early companions to the joint symptoms.
How RA Is Diagnosed
There’s no single test that confirms RA. Diagnosis relies on a combination of symptoms, physical examination, blood tests, and imaging. Two blood tests play a central role. Rheumatoid factor (RF) is the older of the two, with a sensitivity ranging from 55% to 90%, but it also shows up in many people who don’t have RA, giving it a positive predictive value of only about 30%. The anti-CCP antibody test is more precise: it correctly identifies about 65% of RA cases while being far more specific, with a positive predictive value around 96%. In practical terms, a positive anti-CCP result makes an RA diagnosis very likely, but a negative result doesn’t rule it out.
Blood markers of general inflammation, such as ESR and CRP, help gauge how active the disease is. X-rays and ultrasound can reveal joint damage or increased blood flow to inflamed tissue. In early RA, imaging may look completely normal, which is why doctors weigh the full clinical picture rather than relying on any single finding.
Four Stages of Disease Progression
RA progresses through recognizable stages, though the timeline varies enormously depending on how aggressive the disease is and how early treatment begins.
- Stage 1: Inflammation develops in the tissue surrounding the joint. You may notice pain and stiffness, but X-rays typically show no bone damage yet.
- Stage 2: Inflammation begins eroding cartilage. Stiffness worsens, and range of motion starts to shrink.
- Stage 3: Damage extends to the bone itself. Pain and stiffness intensify, and visible changes to joint shape may appear.
- Stage 4: Active inflammation may slow or stop, but the accumulated damage continues to worsen. Severe pain, swelling, stiffness, and significant loss of mobility characterize this stage.
The goal of modern treatment is to prevent progression beyond stage 1 or 2. With early, aggressive therapy, many people never reach the later stages.
Effects Beyond the Joints
RA is a systemic disease, meaning it can affect your entire body, not just your joints. Roughly 40% of people with RA experience problems outside the musculoskeletal system. The inflammation that drives joint damage can also target the heart, lungs, eyes, skin, blood vessels, kidneys, and nervous system.
Cardiovascular disease is the most serious of these complications and a leading cause of reduced life expectancy in people with RA. Chronic inflammation accelerates the buildup of plaque in blood vessels. Lung involvement can take the form of scarring or inflammation of the lung lining. Dry eyes and dry mouth are common. Small, firm bumps called rheumatoid nodules can form under the skin, particularly near the elbows. Controlling the underlying inflammation with effective treatment reduces the risk of most of these complications.
How RA Is Treated
The standard approach to RA follows a “treat-to-target” strategy: the goal is clinical remission, defined as the absence of meaningful signs and symptoms of inflammatory disease activity. When full remission isn’t achievable, particularly in long-standing disease, low disease activity is an acceptable alternative target. Treatment is adjusted at least every three months until the target is reached, with regular monitoring to make sure it’s maintained.
The first medication most people receive is methotrexate, taken once weekly, often alongside a short course of a low-dose steroid to quickly bring inflammation under control. Methotrexate is the most consistently effective initial treatment and remains the backbone of RA therapy for most patients. Folic acid supplementation is given alongside it to reduce side effects like nausea and mouth sores.
If methotrexate alone doesn’t bring the disease under adequate control within three to six months, the next step is adding a biologic medication. Biologics are injectable or infused drugs that block specific immune signals. TNF inhibitors were the first class developed and remain widely used. Other biologics target different parts of the immune response, including the IL-6 pathway and specific immune cell types. A newer class of oral medications called JAK inhibitors works by blocking signaling pathways inside immune cells, though doctors weigh cardiovascular and other risks before prescribing them.
If the first biologic doesn’t work well enough, switching to a different one, even within the same class, is a standard and often successful strategy. The number of available options means that most people can find a combination that brings their disease to a manageable level.
Living With RA Day to Day
Beyond medication, regular physical activity is one of the most effective ways to manage RA symptoms. Low-impact exercise like swimming, cycling, and walking helps maintain joint flexibility, strengthen the muscles that support your joints, and reduce fatigue. Many people benefit from working with a physical or occupational therapist, especially early on, to learn joint-protective techniques for everyday tasks.
Flares, periods when symptoms temporarily worsen, are a normal part of living with RA even when treatment is working well. Learning to pace activities, manage stress, and recognize early flare signs gives you more control over how the disease affects your daily life. With current treatments and a proactive approach, most people with RA maintain active, productive lives, a dramatic shift from just a few decades ago when joint destruction and disability were far more common outcomes.